CD10 by IHC

CD10 by IHC (Immunohistochemistry)

Test Overview:
CD10 by Immunohistochemistry (IHC) is a diagnostic test used to detect the presence of the CD10 protein (also called Common Acute Lymphoblastic Leukemia Antigen – CALLA) in tissue samples. It helps pathologists identify and classify certain types of cancers and hematologic disorders.

Why is this test done?

• Assists in diagnosing specific lymphomas and leukemias
• Helps classify tumors and differentiate cancer types
• Supports identification of certain kidney, endometrial, and other tumors
• Helps guide treatment planning and prognosis evaluation

Sample Required:

• Tissue specimen / biopsy sample preserved for histopathological examination

Method:

• Immunohistochemistry (IHC)

Preparation:

• No special preparation is generally required

Benefits:

• Supports accurate tumor classification
• Helps distinguish between similar-looking cancers
• Assists clinicians in selecting appropriate treatment strategies

Turnaround Time:

• Usually depends on laboratory processing protocols

Note:
Test interpretation should always be correlated with clinical history, imaging findings, and other pathology investigations.

Shopify short description:
CD10 by IHC is an advanced diagnostic test that detects CD10 protein expression in tissue samples, aiding in cancer diagnosis, tumor classification, and treatment planning.